ResearcherShanghai Medical College of Fudan UniversityNo recent work listed
Xiaofeng Yu
Matched on ORCID iD 0000-0002-2151-0099; OpenAlex author ID A5100658049. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper
Papers 2
- Triptolide enhances the sensitivity of pancreatic cancer PANC-1 cells to gemcitabine by inhibiting TLR4/NF-κB signaling. Last author PMID 31312385↗
- Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF. Last author DOI 10.3727/096504013x13657689382932↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yunliang Sun · 2 shared papers, 2013–2019 · strength 0.16
- Paper Triptolide enhances the sensitivity of pancreatic cancer PANC-1 cells to gemcitabine by inhibiting TLR4/NF-κB signaling. PMID 31312385↗
- Paper Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulatin… DOI 10.3727/096504013x13657689382932↗
- Hongyu Wu · 2 shared papers, 2013–2019 · strength 0.16
- Paper Triptolide enhances the sensitivity of pancreatic cancer PANC-1 cells to gemcitabine by inhibiting TLR4/NF-κB signaling. PMID 31312385↗
- Paper Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulatin… DOI 10.3727/096504013x13657689382932↗
- Jianxia Ma · 1 shared paper, 2019 · strength 0.11
- Jianxia Ma · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.